SCHEMBL3713449

SCHEMBL3713449

NCCCn1cc(Cl)c2cnc(Cl)nc21

nearest known ligand 0.40

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 14/20 0.40
GSK3B P49841 1/20 0.33
CDK1 P06493 1/20 0.30
PAK1 Q13153 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3715755 0.85 GSK3B (0.32) GSK3B
SCHEMBL31177281 0.85 LRRK2 (0.40) LRRK2GSK3BCDK1
SCHEMBL21087557 0.79 LRRK2 (0.53) LRRK2
SCHEMBL3713447 0.78 LRRK2 (0.38) LRRK2
SCHEMBL31177303 0.75 DUT (0.42) LRRK2
SCHEMBL21087554 0.74 LRRK2 (0.40) LRRK2
SCHEMBL3712175 0.74 PAK1 (0.35) GSK3BCDK1PAK1
SCHEMBL3713884 0.72 CDK4 (0.48) LRRK2CDK1
SCHEMBL1284361 0.72 TBK1 (0.40) LRRK2
SCHEMBL22518612 0.72 LRRK2 (0.52) LRRK2CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2403853-B1 PYRROLOPYRIMIDINES USED AS KINASE INHIBITORS MEDICAL RES COUNCIL TECHNOLOGY (GB) 2013-08-14 EP disclosed
WO-2010100431-A1 PYRROLOPYRIMIDINES USED AS KINASE INHIBITORS MEDICAL RESEARCH COUNCIL TECHNOLOGY (GB) 2010-09-10 WO disclosed